Evaluation of breast stiffness pathology based on breast compression during mammography: Proposal for novel breast stiffness scale classification

Carregando...
Imagem de Miniatura
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER ESPANA
Autores
PROKOP, Jiri
MARSALEK, Pavel
SENGUL, Ilker
PELIKAN, Anton
JANOUTOVA, Jana
HORYL, Petr
ROMAN, Jan
SENGUL, Demet
Citação
CLINICS, v.77, article ID 100100, 12p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Breast cancer is diagnosed through a patient's Breast Self-Examination (BSE), Clinical Breast Examination (CBE), or para-clinical methods. False negativity of PCM in breast cancer diagnostics leads to a persisting problem associ-ated with breast tumors diagnosed only in advanced stages. As the tumor volume/size at which it becomes inva-sive is not clear, BSE and CBE play an exceedingly important role in the early diagnosis of breast cancer. The quality and effectiveness of BSE and CBE depend on several factors, among which breast stiffness is the most important one. In this study, the authors present four methods for evaluating breast stiffness pathology during mammography examination based on the outputs obtained during the breast compression process, id est, without exposing the patient to X-Ray radiation. Based on the subjective assessment of breast stiffness by experienced medical examiners, a novel breast stiffness classification was designed, and the best method of its objective mea-surement was calibrated to fit the scale. Hence, this study provides an objective tool for the identification of patients who, being unable to perform valid BSE, could benefit from an increased frequency of mammography screening. Dum vivimus servimus.
Palavras-chave
Brasil, Breast, Mammography, Stiffness, Breast pathology, Novel, Scale
Referências
  1. Alowami S, 2003, BREAST CANCER RES, V5, pR129, DOI 10.1186/bcr622
  2. Aydin I, 2021, CUREUS, V13, DOI 10.7759/cureus.15206
  3. Bennett RL, 2011, BRIT J CANCER, V104, P571, DOI 10.1038/bjc.2011.3
  4. Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790
  5. Boyd NF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100937
  6. Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544
  7. Chaudhuri O, 2014, NAT MATER, V13, P970, DOI [10.1038/nmat4009, 10.1038/NMAT4009]
  8. Vieira RAD, 2017, CLINICS, V72, P244, DOI 10.6061/clinics/2017(04)09
  9. Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1
  10. Doyley MM, 2012, PHYS MED BIOL, V57, pR35, DOI 10.1088/0031-9155/57/3/R35
  11. Feinberg AP, 2014, J INTERN MED, V276, P5, DOI 10.1111/joim.12224
  12. Hagios C, 1998, PHILOS T R SOC B, V353, P857, DOI 10.1098/rstb.1998.0250
  13. Howard CV, 1999, SOC CELLS CANC CONTR, P518
  14. Kirsh VA, 2011, JNCI-J NATL CANCER I, V103, P942, DOI 10.1093/jnci/djr138
  15. Li JM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3238
  16. Li T, 2005, CANCER EPIDEM BIOMAR, V14, P343, DOI 10.1158/1055-9965.EPI-04-0490
  17. Marsalek P, 2021, MATERIALS, V14, DOI 10.3390/ma14010140
  18. McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034
  19. McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624
  20. Mokhatri-Hesari P, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01591-x
  21. Ophir J, 1999, P I MECH ENG H, V213, P203, DOI 10.1243/0954411991534933
  22. Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x
  23. Provencher L, 2016, CURR ONCOL, V23, pE332, DOI 10.3747/co.23.2881
  24. Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11
  25. Ramiao NG, 2016, BIOMECH MODEL MECHAN, V15, P1307, DOI 10.1007/s10237-016-0763-8
  26. Saarenmaa I, 2001, BREAST CANCER RES TR, V67, P117, DOI 10.1023/A:1010627527026
  27. Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
  28. Smardova J, 2016, Klin Onkol, V29, P259
  29. Sotola M, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12111837
  30. Thomas DB, 2002, JNCI-J NATL CANCER I, V94, P1445, DOI 10.1093/jnci/94.19.1445
  31. Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486
  32. Ngan TT, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07521-w
  33. Weiss Noel S, 2003, Breast J, V9 Suppl 2, pS86, DOI 10.1046/j.1524-4741.9.s2.9.x